Actinogen Medical Limited carries a market capitalization of 2.97M, placing it among publicly traded companies globally.
| Market Cap | 2.97M |
| Enterprise Value | N/A |
Actinogen Medical Limited's stock has declined approximately -96% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -96% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Actinogen Medical Limited's most recent stock split took place on September 27, 2023 with a 1000:1041 split ratio.
| Last Split Date | 9/27/2023 |
| Split Ratio | 1000:1041 |